SSL International plc

Venus, 1 Old Park Lane, Trafford Park, Urmston, Manchester, M41 7HA , UK
Telephone: +44 (0)8701 222 690
Fax: +44 (0)8701 222 696
WWW: http://www.ssl-international.com
Medical Information Direct Line: +44 (0)161 638 2027
Medical Information e-mail: medical.information@ssl-international.com
Customer Care direct line: +44 (0)161 638 2399
Medical Information Fax: +44 (0)161 615 8819

Summary of Product Characteristics last updated on the eMC: 28/09/2006
SPC Merocets Plus


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Merocets Plus.


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Cetylpyridinium Chloride EP 1.4mg; Menthol EP 5.0mg;Eucalyptus Oil 3.0mg.


Go to top of the page
3. PHARMACEUTICAL FORM

Lozenge.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

Symptomatic treatment of sore throat. Symptomatic relief of nasal congestion.


Go to top of the page
4.2 Posology and method of administration

Oral: Adults and children over 6 years: One lozenge every 3 hours. Allow the lozenge to dissolve slowly in the mouth.


Go to top of the page
4.3 Contraindications

Known idiosyncrasy to cetylpyridinium chloride and menthol.


Go to top of the page
4.4 Special warnings and precautions for use

If sore throat persists consult a doctor.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None known.


Go to top of the page
4.6 Pregnancy and lactation

There is no or inadequate evidence of safety of cetylpyridinium chloride in human pregnancy but it has been in wide use for many years without apparent ill consequences. No data are available on the use of Merocets Plus in pregnancy.


Go to top of the page
4.7 Effects on ability to drive and use machines

None known.


Go to top of the page
4.8 Undesirable effects

Very rare reports of urticaria. Infrequent and transient complaints of a burning sensation of the mouth.


Go to top of the page
4.9 Overdose

No experience of overdosage but normal procedures of gastric lavage and maintenance of respiration and circulation should apply.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Cetylpyridinium chloride is a surface active quaternary ammonium compound with antibacterial properties.


Go to top of the page
5.2 Pharmacokinetic properties

Cetylpyridinium chloride exerts its antimicrobial activity topically in the mouth and throat as it dissolves from the lozenge. Pharmacokinetic data are not available.


Go to top of the page
5.3 Preclinical safety data

None stated.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Sucrose, granular; Glucose Liquid; Ethyl Alcohol; Purified Water


Go to top of the page
6.2 Incompatibilities

Not applicable.


Go to top of the page
6.3 Shelf life

36 months unopened.


Go to top of the page
6.4 Special precautions for storage

Do not store above 25°C


Go to top of the page
6.5 Nature and contents of container

PVC/PVdC/aluminium foil laminate blister in cardboard cartons. Packs of 24 lozenges.


Go to top of the page
6.6 Special precautions for disposal and other handling

None stated.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

SSL International PLC. Venus, 1 Old Park Lane, Trafford Park, Manchester, M41 7HA.


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 17905/0069


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

23/03/06


Go to top of the page
10. DATE OF REVISION OF THE TEXT

23/03/06



More information about this product

Link to this document from your website: http://emc.medicines.org.uk/medicine/4474/SPC/Merocets Plus/


Active Ingredients/Generics

 
   eucalyptus oil
   cetylpyridinium chloride
   menthol


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk